ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Gori Tells McGovern Committee Diet Causes Major Share Of Cancer

August 6, 1976

Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible

May 26, 1995

Largest Oncological Society Exerts Clout, Getting Results

June 24, 1983